ACTA GASTRO-ENTEROLOGICA BELGICA, cilt.79, sa.2, ss.206-210, 2016 (SCI-Expanded)
Aim : Few data are available regarding the effects of interleukin 28B (IL28B) polymorphisms in chronic hepatitis D (CHD) patients. This study investigated the relationship between IL28B polymorphisms and the response of patients with CHD infections to pegylated interferon (PEG-IFN) therapy.